IQVIA Holdings, Inc. Common Stock (IQV)

This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000.

Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238.

Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...

Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billi...

IQVIA (NYSE:IQV) reported second-quarter results that exceeded the high end of its guidance, supported by accelerating organic revenue growth, higher R&D Solutions bookings and operational productivity gains. The company also raised its full-year outlook for revenue, adjusted EBITDA and adjusted dil

What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results th...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billion. The compa...

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. IQVIA beat analysts’ r...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 5.8% in the afternoon session after Baird raised its price target on the stock to...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Over the last six months, IQVIA’s shares have sunk to $177.52, producing a disappointing 19.8% loss - a stark contrast to the S&P 500’s 12.4% gain. This migh...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...